GenScript receives FDA emergency approvals for use of cPass (TM) SARS-CoV-2 Neutralization antibody test during plasma repair
:quality(85)//cloudfront-us-east-1.images.arcpublishing.com/infobae/SVNDND5QFRHJFKFJK3X3I26QYE.jpg "BioNTech warns of lack of vacancies against coronavirus during regulatory approvals demonstrations")
